The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the blood of someone who doesn’t have the disease. When used alongside the existing CA 19-9 test, it was able to diagnose early-stage pancreatic cancer with 85% accuracy.

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly 52,000 will die from the disease.

Paired with an existing test, this could become a life-saving diagnostic tool for people with a notoriously deadly form of cancer.

Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the most deadly forms of the disease. Tests showed up to 85% accuracy in detection,